A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...

Emerging evidence shows glucose-lowering medications may have the potential to improve chronic obstructive pulmonary disease ...

LG Chem, Korea's leading chemical company, said Monday the accumulated sales of its own diabetes drug have exceeded 1 ...

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8541 ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

The bioengineered protein drugs market is experiencing a paradigm shift, with pharmaceutical and biotech companies leveraging advanced biopharmaceuti ...

Here are the critical medicines in short supply in the EU, according to the latest available information from the EMA and ...

One of the most highly anticipated FDA decisions this month is for Alnylam Pharmaceuticals, which is seeking to expand the ...

Consumers are on board, with an estimated 26% of U.S. adults planning to take a weight loss drug in 2025, according to ...

London: GSK plc has announced the US Food and Drug Administration (FDA) has accepted for review the Biologics License ...

Everyone is talking about or using weight loss products. So, the government pounces. A batch of 17 drugs are on a list of medications in a second round of ...